LakeShore Biopharma Co., Ltd (LSB)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Gang Li | Head of Marketing & Sales | -- | -- | 1982 |
| Dr. Yuan Liu Ph.D. | Head of Vaccine Research | -- | -- | 1987 |
| Mr. Wang Xu | CEO & Director | -- | -- | 1971 |
| Dr. Hui Shao C.F.A., M.B.A., Ph.D. | President, Chief Business Officer & Vice Chairman | -- | -- | 1968 |
| Ms. Rui Yu M.B.A., M.S. | CFO & Director | -- | -- | 1975 |
| Dr. Zenaida Reynoso Mojares M.D. | Chief Medical Officer | -- | -- | 1959 |
LakeShore Biopharma Co., Ltd
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 758
Description
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. The company's product pipeline includes YSJA, a conventional rabies vaccine which is in marketed stage; PIKA, a rabies vaccine which are in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic that is in phase I trials for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine that is in phase I trials; PIKA YS-HBV-002, an immune-therapy vaccine which is in IND preclinical trials for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine which are in preclinical trials. It operates in China, Singapore, the United States, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. The company was founded in 2002 and is based in Beijing, China.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
July 31, 2024 at 12:00 AM UTC
NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F